Asymptote combines world leading research into the science of cell freezing with engineering expertise to create pioneering cryochain technology for advanced medicines. Our portfolio of innovative products preserve cell viability during cryogenic processing of cellular therapies – their freezing, shipping and thawing – to support our customers’ work to improve healthcare throughout the world.
The Leadership Team
Dr John Morris
Dr Chris Creasey
Dr Stuart Milne
Asymptote’s cryochain technology comprises of integrated hardware, software and consumables. Our my.Cryochain software is the only platform developed specifically to control the cryochain of cellular therapies. All Asymptote’s hardware synchronize with my.Cryochain to standardize processes at all sites and centrally audit remote data. Our liquid-nitrogen free, GMP compatible equipment - the VIA Freeze range of controlled rate freezers, the up-coming VIA Shipper and the automated thawing systems for cryobags and cryovials - manage the end-to-end cryochain. Cryochain consumables are in development, these include IceStart, an ice nucleator to ensure consistent freezing in multiwell plates.
The Asymptote GMP Cold Chain
As can be seen in the above illustration, Asymptote will release numerous products to fulfill user requirements at each stage in the cold-chain. Details of these products can be found in the products section of the website as they become available. If you are interested in our current development progress please do not hesitate toto learn more.
We believe that taking a considered approach to the way we do things makes for a great product and a great company. We are serious about minimising our environmental footprint, and each business decision is weighted by its environmental impact. Our design process preferentially selects materials and processes that best support this aim, and we try as best as possible to avoid any unnecessary waste.
We have designed End-Of-Life recyclability into our products. Simplyand we will arrange for collection and recycling of any unwanted Asymptote equipment.
Carbon footprint management
Asymptote manufactures all non-OEM components in the UK and selects manufacturing sub-contractors based upon their environmental policies and record. This significantly reduces the material, process waste and transportation costs associated with our manufacturing activities. In the course of our business we minimise travel wherever possible, and when it is unavoidable, we carbon offset our emissions.
Cryocooling vs liquid nitrogen
Use of stirling cryocoolers instead of liquid nitrogen is not only preferable in terms of reduced sample contamination (liquid nitrogen carries numerous undesirable particulates) and health and safety improvements, but it is an inherently more efficient approach. The types of stirling cryocoolers we use convert 30%* of their input electrical power into actual cooling power, greatly exceeding the lifecycle costs involved with using liquid nitrogen.
(*Performance averaged over freezing cycle)
Company car policy
Whilst some of us love sports cars and the joy they bring, in Cambridge at least, greater joys still are to be found overtaking cars stuck in traffic jams. More than 75% of the company commutes to work by bicycle each day.
Asymptote are always on the look out for excellent people to join our team. If you think you could make a contribution to Asymptote, please do. Even if we are not currently advertising for your specific skillset, we would love to hear from you.
Please do not hesitate to contact us with any questions by email or telephone.
Tel +44(0)1223 421161
St. John's Innovation Centre